论文部分内容阅读
目的:探究呼吸机相关性肺炎预防中通过集束化治疗后取得的临床成效。方法:选取我院2014年1月-2016年6月进行机械通气的患者80例,依随机分组标准分为观察组(40人)和对照组(40人)。对照组患者治疗方法为常规基础治疗,观察组为集束化治疗。从平均拔管时间、住ICU时间,发病率及生存质量四方面入手,针对相关内容进行分析。结果:在平均拔管时间、住ICU时间方面,观察组均明显低于对照组(P<0.05);针对发病率情况,观察组发生率(15%)显著低于对照组(30%),(P<0.05);在生存质量方面,观察组患者各项指标得分均比对照组高(P<0.05)。结论:呼吸机相关性肺炎预防中通过集束化治疗后取得的临床成效显著,在缩短拔管时间和住ICU时间的同时,使发病率明显降低,且患者生存质量显著改善,值得在临床予以推广应用。
OBJECTIVE: To investigate the clinical outcomes of cluster pneumoconiosis in the prevention of ventilator-associated pneumonia. Methods: Eighty patients with mechanical ventilation from January 2014 to June 2016 in our hospital were selected and randomly divided into observation group (40 persons) and control group (40 persons). Control group patients with conventional basic treatment, the observation group for the cluster therapy. From the average extubation time, living in ICU time, morbidity and quality of life in four aspects, to analyze the relevant content. Results: The average time of extubation and ICU stay in the observation group were significantly lower than those in the control group (P <0.05). The morbidity of the observation group (15%) was significantly lower than that of the control group (30%), (P <0.05). In terms of quality of life, the score of each index in the observation group was higher than that of the control group (P <0.05). CONCLUSIONS: The clinical efficacy achieved by cluster therapy in the prevention of ventilator-associated pneumonia is significant. While reducing the time for extubation and ICU stay, the incidence is significantly reduced, and the quality of life of patients is significantly improved, which is worth to be popularized clinically application.